Low-Risk Childhood Hodgkin Lymphoma
Intermediate-Risk Childhood Hodgkin Lymphoma
High-Risk Childhood Hodgkin Lymphoma
Nodular Lymphocyte Predominant Childhood Hodgkin Lymphoma

A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.

Treatment of low-risk childhood Hodgkin lymphoma may include the following:

• Combination chemotherapy with low- dose radiation therapy to involved areas.
• A clinical trial of combination chemotherapy with or without low-dose radiation therapy to involved areas.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage I childhood Hodgkin lymphoma and stage II childhood Hodgkin lymphoma.

Treatment of intermediate-risk childhood Hodgkin lymphoma may include the following:

• Combination chemotherapy with low- dose radiation therapy to involved areas.
• A clinical trial of combination chemotherapy with or without low-dose radiation therapy to involved areas.
• A clinical trial of new combinations of chemotherapy before low-dose radiation therapy to involved areas.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage I childhood Hodgkin lymphoma, stage II childhood Hodgkin lymphoma, stage III childhood Hodgkin lymphoma and stage IV childhood Hodgkin lymphoma.

Treatment of high-risk childhood Hodgkin lymphoma may include intensive or high-dose combination chemotherapy with low- dose radiation therapy to involved areas.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage III childhood Hodgkin lymphoma and stage IV childhood Hodgkin lymphoma.

Treatment of nodular lymphocyte predominant childhood Hodgkin lymphoma may include the following:

• Combination chemotherapy with low- dose radiation therapy to involved areas.
• Combination chemotherapy.
• Surgery.
• A clinical trial of surgery to remove a single lymph node.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with childhood nodular lymphocyte predominant Hodgkin lymphoma.

Back to Top

< Previous Section  |  Next Section >